Literature DB >> 11431361

Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.

N Liu1, F Gao, Z Han, X Xu, C B Underhill, L Zhang.   

Abstract

Hyaluronan synthase 3 (HAS3) is responsible for the production of both secreted and cell-associated forms of hyaluronan and is the most active of the three isoforms of this enzyme in adults. In this study, the cDNA for human HAS3 was cloned and characterized. The open reading frame consisted of 1659 bp coding for 553 amino acids with a deduced molecular weight of about 63,000 and isoelectric pH of 8.70. The sequence of human HAS3 displayed a 53% identity to HAS1 and a 67% identity to HAS2. It also contained a signal peptide and six potential transmembrane domains, suggesting that it was associated with the plasma membrane. To evaluate the physiological role of human HAS3, expression vectors for this protein were transfected into TSU cells (a prostate cancer cell line), and the phenotypic changes in these cells were examined. The enhanced expression of hyaluronan in the transfected cells was demonstrated by dot blot analysis and ELISA. These cells were found to differ from their vector-transfected counterparts with respect to the following: (a) they grew at a faster rate in high (but not low) density cultures; (b) conditioned media from these cells stimulated the proliferation and migration of endothelial cells; (c) when placed on the chorioallantoic membrane of chicken embryos, these cells formed large, dispersed xenografts, whereas the control transfectants formed compact masses; and (d) when injected s.c. into nude mice, the xenografts formed by HAS3 transfectants were bigger than those formed by control transfectants. Histological examination of these xenografts revealed the presence of extracellular hyaluronan that could act as conduits for the diffusion of nutrients. In addition, they had a greater number of blood vessels. However, the HAS3-transfected TSU cells did not display increased metastatic properties as judged by their ability to form lung masses after i.v. injection. These results suggested that the HAS3-induced overexpression of hyaluronan enhanced tumor cell growth, extracellular matrix deposition, and angiogenesis but was not sufficient to induce metastatic behavior in TSU cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431361

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

1.  Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration.

Authors:  Naoki Itano; Fukiko Atsumi; Takahiro Sawai; Yoichi Yamada; Osamu Miyaishi; Takeshi Senga; Michinari Hamaguchi; Koji Kimata
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 2.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

3.  Hyaluronan and tumor growth.

Authors:  Bryan P Toole; Vincent C Hascall
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

4.  Caution should be used in long-term treatment with oral compounds of hyaluronic acid in patients with a history of cancer.

Authors:  Procopio Simone; Migliore Alberto
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

Review 5.  Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule.

Authors:  Karl M Stuhlmeier
Journal:  Wien Med Wochenschr       Date:  2006-11

6.  HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.

Authors:  I-Wei Chang; Peir-In Liang; Ching-Chia Li; Wen-Jeng Wu; Chun-Nung Huang; Victor Chia-Hsiang Lin; Chao-Tien Hsu; Hong-Lin He; Ting-Feng Wu; Chih-Hsin Hung; Chien-Feng Li
Journal:  Tumour Biol       Date:  2015-05-02

7.  Hyaluronan expression as a significant prognostic factor in patients with malignant peripheral nerve sheath tumors.

Authors:  Kunihiro Ikuta; Hiroshi Urakawa; Eiji Kozawa; Eisuke Arai; Lisheng Zhuo; Naohisa Futamura; Shunsuke Hamada; Koji Kimata; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Clin Exp Metastasis       Date:  2014-06-24       Impact factor: 5.150

8.  Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice.

Authors:  Melanie A Simpson
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

9.  Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases.

Authors:  Guang Dai; Till Freudenberger; Petra Zipper; Ariane Melchior; Susanne Grether-Beck; Berit Rabausch; Jens de Groot; Sören Twarock; Helmut Hanenberg; Bernhard Homey; Jean Krutmann; Julia Reifenberger; Jens W Fischer
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

Review 10.  Role of Pericellular Matrix in the Regulation of Cancer Stemness.

Authors:  Sofia Avnet; Margherita Cortini
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.